Cell-based regeneration and treatment of liver diseases

17Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suffering from end-stage liver disease is liver transplantation. However, the number of donor livers required by far surpasses the supply, leading to a significant organ shortage. Cellular therapies play an increasing role in the restoration of organ function and can be integrated into organ transplantation protocols. Different types and sources of stem cells are considered for this purpose, but highly specific immune cells are also the focus of attention when developing individualized therapies. In-depth knowledge of the underlying mechanisms governing cell differentiation and engraftment is crucial for clinical implementation. Additionally, novel technologies such as ex vivo machine perfusion and recent developments in tissue engineering may hold promising potential for the implementation of cell-based therapies to restore proper organ function.

Cite

CITATION STYLE

APA

Hofmann, J., Hackl, V., Esser, H., Meszaros, A. T., Fodor, M., Öfner, D., … Hautz, T. (2021, October 1). Cell-based regeneration and treatment of liver diseases. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms221910276

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free